Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1984 Sep;52(3):241–247. doi: 10.1136/hrt.52.3.241

Prophylaxis of primary ventricular fibrillation in acute myocardial infarction. The case against lignocaine.

P Kertes, D Hunt
PMCID: PMC481620  PMID: 6380549

Full text

PDF
241

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adgey A. A., Allen J. D., Geddes J. S., James R. G., Webb S. W., Zaidi S. A., Pantridge J. F. Acute phase of myocardial infarction. Lancet. 1971 Sep 4;2(7723):501–504. doi: 10.1016/s0140-6736(71)90434-x. [DOI] [PubMed] [Google Scholar]
  2. Bennett M. A., Wilner J. M., Pentecost B. L. Controlled trial of lignocaine in prophylaxis of ventricular arrhythmias complicating myocardial infarction. Lancet. 1970 Oct 31;2(7679):909–911. doi: 10.1016/s0140-6736(70)92073-8. [DOI] [PubMed] [Google Scholar]
  3. Bleifeld W., Merx K. W., Heinrich K. W., Effert S. Controlled trial of prophylatic treatment with lidocaine in acute myocardial infarction. Eur J Clin Pharmacol. 1973 Aug;6(2):119–126. doi: 10.1007/BF00562438. [DOI] [PubMed] [Google Scholar]
  4. Breithardt G., Borggrefe M., Quantius B., Karbenn U., Seipel L. Ventricular vulnerability assessed by programmed ventricular stimulation in patients with and without late potentials. Circulation. 1983 Aug;68(2):275–281. doi: 10.1161/01.cir.68.2.275. [DOI] [PubMed] [Google Scholar]
  5. Campbell R. W., Hutton I., Elton R. A., Goodfellow R. M., Taylor E. Prophylaxis of primary ventricular fibrillation with tocainide in acute myocardial infarction. Br Heart J. 1983 Jun;49(6):557–563. doi: 10.1136/hrt.49.6.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Campbell R. W., Murray A., Julian D. G. Ventricular arrhythmias in first 12 hours of acute myocardial infarction. Natural history study. Br Heart J. 1981 Oct;46(4):351–357. doi: 10.1136/hrt.46.4.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Campbell R. W. Placebo controlled study of prophylaxis of ventricular arrhythmias in acute myocardial infarction. Am Heart J. 1980 Dec;100(6 Pt 2):995–999. doi: 10.1016/0002-8703(80)90203-3. [DOI] [PubMed] [Google Scholar]
  8. Carruth J. E., Silverman M. E. Ventricular fibrillation complicating acute myocardial infarction: reasons against the routine use of lidocaine. Am Heart J. 1982 Sep;104(3):545–550. doi: 10.1016/0002-8703(82)90225-3. [DOI] [PubMed] [Google Scholar]
  9. Chopra M. P., Thadani U., Portal R. W., Aber C. P. Lignocaine therapy for ventricular ectopic activity after acute myocardial infarction: a double-blind trial. Br Med J. 1971 Sep 18;3(5776):668–670. doi: 10.1136/bmj.3.5776.668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Collinsworth K. A., Kalman S. M., Harrison D. C. The clinical pharmacology of lidocaine as an antiarrhythymic drug. Circulation. 1974 Dec;50(6):1217–1230. doi: 10.1161/01.cir.50.6.1217. [DOI] [PubMed] [Google Scholar]
  11. Darby S., Cruickshank J. C., Bennett M. A., Pentecost B. L. Trial of combined intramuscular and intravenous lignocaine in prophylaxis of ventricular tachyarrhythmias. Lancet. 1972 Apr 15;1(7755):817–819. doi: 10.1016/s0140-6736(72)90801-x. [DOI] [PubMed] [Google Scholar]
  12. DeSilva R. A., Hennekens C. H., Lown B., Casscells W. Lignocaine prophylaxis in acute myocardial infarction: an evaluation of randomised trials. Lancet. 1981 Oct 17;2(8251):855–858. doi: 10.1016/s0140-6736(81)91116-8. [DOI] [PubMed] [Google Scholar]
  13. Dhurandhar R. W., MacMillan R. L., Brown K. W. Primary ventricular fibrillation complicating acute myocardial infarction. Am J Cardiol. 1971 Apr;27(4):347–351. doi: 10.1016/0002-9149(71)90429-2. [DOI] [PubMed] [Google Scholar]
  14. El-Sherif N., Myerburg R. J., Scherlag B. J., Befeler B., Aranda J. M., Castellanos A., Lazzara R. Electrocardiographic antecedents of primary ventricular fibrillation. Value of the R-on-T phenomenon in myocardial infarction. Br Heart J. 1976 Apr;38(4):415–422. doi: 10.1136/hrt.38.4.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gamble O. W., Cohn K. Effect of propranolol, procainamide, and lidocaine on ventricular automaticity and reentry in experimental myocardial infarction. Circulation. 1972 Sep;46(3):498–506. doi: 10.1161/01.cir.46.3.498. [DOI] [PubMed] [Google Scholar]
  16. Geddes J. S., Adgey A. A., Pantridge J. F. Prognosis after recovery from ventricular fibrillation complicating ischaemic heart-disease. Lancet. 1967 Aug 5;2(7510):273–275. doi: 10.1016/s0140-6736(67)90111-0. [DOI] [PubMed] [Google Scholar]
  17. Gianelly R., von der Groeben J. O., Spivack A. P., Harrison D. C. Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease. N Engl J Med. 1967 Dec 7;277(23):1215–1219. doi: 10.1056/NEJM196712072772301. [DOI] [PubMed] [Google Scholar]
  18. Harrison D. C. Should lidocaine be administered routinely to all patients after acute myocardial infarction? Circulation. 1978 Oct;58(4):581–584. doi: 10.1161/01.cir.58.4.581. [DOI] [PubMed] [Google Scholar]
  19. Holmberg S., Rydén L., Waldenström A. Efficiency of arrhythmia detection by nurses in a coronary care unit using a decentralised monitoring system. Br Heart J. 1977 Sep;39(9):1019–1025. doi: 10.1136/hrt.39.9.1019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Jennings G., Jones M. S., Besterman E. M., Model D. G., Turner P. P., Kidner P. H. Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction. Lancet. 1976 Jan 10;1(7950):51–54. doi: 10.1016/s0140-6736(76)90148-3. [DOI] [PubMed] [Google Scholar]
  21. Lawrie D. M., Higgins M. R., Godman M. J., Oliver M. F., Julian D. G., Donald K. W. Ventricular fibrillation complicating acute myocardial infarction. Lancet. 1968 Sep 7;2(7567):523–528. doi: 10.1016/s0140-6736(68)92403-3. [DOI] [PubMed] [Google Scholar]
  22. Leighton R. F., Wilt S. M., Lewis R. P. Detection of hypokinesis by a quantitative analysis of left ventricular cineangiograms. Circulation. 1974 Jul;50(1):121–127. doi: 10.1161/01.cir.50.1.121. [DOI] [PubMed] [Google Scholar]
  23. Lie K. I., Liem K. L., Louridtz W. J., Janse M. J., Willebrands A. F., Durrer D. Efficacy of lidocaine in preventing primary ventricular fibrillation within 1 hour after a 300 mg intramuscular injection. A double-blind, randomized study of 300 hospitalized patients with acute myocardial infarction. Am J Cardiol. 1978 Sep;42(3):486–488. doi: 10.1016/0002-9149(78)90945-1. [DOI] [PubMed] [Google Scholar]
  24. Lie K. I., Wellens H. J., Downar E., Durrer D. Observations on patients with primary ventricular fibrillation complicating acute myocardial infarction. Circulation. 1975 Nov;52(5):755–759. doi: 10.1161/01.cir.52.5.755. [DOI] [PubMed] [Google Scholar]
  25. Lie K. I., Wellens H. J., Durrer D. Characteristics and predictability of primary ventricular fibrillation. Eur J Cardiol. 1974 Apr;1(4):379–384. [PubMed] [Google Scholar]
  26. Lie K. I., Wellens H. J., Liem K. L., Durrer D. Treatment and prevention of primary ventricular fibrillation complicating acute myocardial infarction. Acta Cardiol. 1977;Suppl 22:107–120. [PubMed] [Google Scholar]
  27. Lie K. I., Wellens H. J., van Capelle F. J., Durrer D. Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients. N Engl J Med. 1974 Dec 19;291(25):1324–1326. doi: 10.1056/NEJM197412192912504. [DOI] [PubMed] [Google Scholar]
  28. Logan K. R., McIlwaine W. J., Adgey A. A., Pantridge J. F. Recurrence of ventricular fibrillation in acute ischemic heart disease. Circulation. 1981 Dec;64(6):1163–1167. doi: 10.1161/01.cir.64.6.1163. [DOI] [PubMed] [Google Scholar]
  29. Logan K. R., McIlwaine W. J., Adgey A. A., Pantridge J. F. Ventricular fibrillation and its recurrence in early acute myocardial infarction. Lancet. 1981 Jan 31;1(8214):242–244. doi: 10.1016/s0140-6736(81)92086-9. [DOI] [PubMed] [Google Scholar]
  30. Lown B., Fakhro A. M., Hood W. B., Jr, Thorn G. W. The coronary care unit. New perspectives and directions. JAMA. 1967 Jan 16;199(3):188–198. [PubMed] [Google Scholar]
  31. Lown B. Lidocaine: antiarrhythmic panacea or cardiac cosmetic agent. JAMA. 1981 Nov 27;246(21):2482–2483. [PubMed] [Google Scholar]
  32. Mogensen L. Ventricular tachyarrhythmias and lignocaine prophylaxis in acute myocardial infarction. A clinical and therapeutic study. Acta Med Scand Suppl. 1970;513:1–80. [PubMed] [Google Scholar]
  33. Nicholls D. P., Haybyrne T., Barnes P. C. Intravenous and oral disopyramide after myocardial infarction. Lancet. 1980 Nov 1;2(8201):936–938. doi: 10.1016/s0140-6736(80)92102-9. [DOI] [PubMed] [Google Scholar]
  34. Noneman J. W., Rogers J. F. Lidocaine prophylaxis in acute myocardial infarction. Medicine (Baltimore) 1978 Nov;57(6):501–515. doi: 10.1097/00005792-197811000-00002. [DOI] [PubMed] [Google Scholar]
  35. Pentecost B. L., De Giovanni J. V., Lamb P., Cadigan P. J., Evemy K. L., Flint E. J. Reappraisal of lignocaine therapy in management of myocardial infarction. Br Heart J. 1981 Jan;45(1):42–47. doi: 10.1136/hrt.45.1.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Pentecost B. L., Mayne N. M. Results of a general hospital coronary care service. Br Med J. 1968 Mar 30;1(5595):830–833. doi: 10.1136/bmj.1.5595.830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Pitt A., Lipp H., Anderson S. T. Lignocaine given prophylactically to patients with acute myocardial infarction. Lancet. 1971 Mar 27;1(7700):612–616. doi: 10.1016/s0140-6736(71)91549-2. [DOI] [PubMed] [Google Scholar]
  38. Prescott L. F., Adjepon-Yamoah K. K., Talbot R. G. Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failure. Br Med J. 1976 Apr 17;1(6015):939–941. doi: 10.1136/bmj.1.6015.939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Ribner H. S., Isaacs E. S., Frishman W. H. Lidocaine prophylaxis against ventricular fibrillation in acute myocardial infarction. Prog Cardiovasc Dis. 1979 Jan-Feb;21(4):287–313. doi: 10.1016/0033-0620(79)90015-x. [DOI] [PubMed] [Google Scholar]
  40. Romhilt D. W., Bloomfield S. S., Chou T. C., Fowler N. O. Unreliability of conventional electrocardiographic monitoring for arrhythmia detection in coronary care units. Am J Cardiol. 1973 Apr;31(4):457–461. doi: 10.1016/0002-9149(73)90294-4. [DOI] [PubMed] [Google Scholar]
  41. Rydén L., Ariniego R., Arnman K., Herlitz J., Hjalmarson A., Holmberg S., Reyes C., Smedgård P., Svedberg K., Vedin A. A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. N Engl J Med. 1983 Mar 17;308(11):614–618. doi: 10.1056/NEJM198303173081102. [DOI] [PubMed] [Google Scholar]
  42. Singh J. B., Kocot S. L. A controlled trial of intramuscular lidocaine in the prevention of premature ventricular contractions associated with acute myocardial infarction. Am Heart J. 1976 Apr;91(4):430–436. doi: 10.1016/s0002-8703(76)80323-7. [DOI] [PubMed] [Google Scholar]
  43. Valentine P. A., Frew J. L., Mashford M. L., Sloman J. G. Lidocaine in the prevention of sudden death in the pre-hospital phase of acute infarction. A double-blind study. N Engl J Med. 1974 Dec 19;291(25):1327–1331. doi: 10.1056/NEJM197412192912505. [DOI] [PubMed] [Google Scholar]
  44. Vetter N. J., Julian D. G. Comparison of arrhythmia computer and conventional monitoring in coronary-care unit. Lancet. 1975 May 24;1(7917):1151–1154. doi: 10.1016/s0140-6736(75)93134-7. [DOI] [PubMed] [Google Scholar]
  45. Weisse A. B., Moschos C. B., Passannante A. J., Khan M. I., Regan T. J. Relative effectiveness of three antiarrhythmic agents in the treatment of ventricular arrhythmias in experimental acute myocardial ischemia. Am Heart J. 1971 Apr;81(4):503–510. doi: 10.1016/0002-8703(71)90366-8. [DOI] [PubMed] [Google Scholar]
  46. Wyman M. G., Hammersmith L. Comprehensive treatment plan for the prevention of primary ventricular fibrillation in acute myocardial infarction. Am J Cardiol. 1974 May 6;33(5):661–667. doi: 10.1016/0002-9149(74)90259-8. [DOI] [PubMed] [Google Scholar]
  47. Zainal N., Carmichael D. J., Griffiths J. W., Besterman E. M., Kidner P. H., Gillham A. D., Summers G. D. Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards. Lancet. 1977 Oct 29;2(8044):887–889. doi: 10.1016/s0140-6736(77)90829-7. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES